Similar articles for PMID: 36881046

Year	Number of Results
1994	1
1996	2
1997	1
1999	2
2002	1
2003	3
2005	1
2006	1
2007	4
2008	1
2010	1
2011	3
2012	3
2013	3
2014	5
2015	5
2016	3
2017	9
2018	7
2019	14
2020	13
2021	17
2022	17
2023	4
2024	0

1

Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging.

Lin YT, Hung SW, Chiu KY, Chai JW, Lin JC. Lin YT, et al. In Vivo. 2023 Mar-Apr;37(2):786-793. doi: 10.21873/invivo.13142. In Vivo. 2023. PMID: 36881046 Free PMC article.

2

The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer.

Zheng S, Jiang S, Chen Z, Huang Z, Shi W, Liu B, Xu Y, Guo Y, Yang H, Li M. Zheng S, et al. PLoS One. 2019 Nov 19;14(11):e0218645. doi: 10.1371/journal.pone.0218645. eCollection 2019. PLoS One. 2019. PMID: 31743339 Free PMC article.

3

Prostate Volume Estimation on MRI: Accuracy and Effects of Ellipsoid and Bullet-Shaped Measurements on PSA Density.

Stanzione A, Ponsiglione A, Di Fiore GA, Picchi SG, Di Stasi M, Verde F, Petretta M, Imbriaco M, Cuocolo R. Stanzione A, et al. Acad Radiol. 2021 Aug;28(8):e219-e226. doi: 10.1016/j.acra.2020.05.014. Epub 2020 Jun 15. Acad Radiol. 2021. PMID: 32553281

4

Which measurement method should be used for prostate volume for PI-RADS? A comparison of ellipsoid and segmentation methods.

Colvin R, Walker D, Hafron J, Seifman B, Nandalur S, Gangwish D, Nandalur KR. Colvin R, et al. Clin Imaging. 2021 Dec;80:454-458. doi: 10.1016/j.clinimag.2021.09.003. Epub 2021 Sep 21. Clin Imaging. 2021. PMID: 34562834

5

[Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].

Zuo MZ, Zhao WL, Wei CG, Zhang CY, Wen R, Gu YF, Li MJ, Zhang YY, Wu JF, Li X, Shen JK. Zuo MZ, et al. Zhonghua Yi Xue Za Zhi. 2017 Dec 19;97(47):3693-3698. doi: 10.3760/cma.j.issn.0376-2491.2017.47.003. Zhonghua Yi Xue Za Zhi. 2017. PMID: 29325321 Chinese.

6

The influence of prostate volume on clinical parameters in prostate cancer screening.

Shan J, Geng X, Lu Y, Liu Z, Zhu H, Zhou R, Zhang Z, Gang X, Zhang D, Shi H. Shan J, et al. J Clin Lab Anal. 2022 Oct;36(10):e24700. doi: 10.1002/jcla.24700. Epub 2022 Sep 13. J Clin Lab Anal. 2022. PMID: 36098911 Free PMC article.

7

Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml^-1.

Wang C, Wang YY, Wang SY, Ding JX, Ding M, Ruan Y, Wang XH, Jing YF, Han BM, Xia SJ, Jiang CY, Zhao FJ. Wang C, et al. Asian J Androl. 2021 Jul-Aug;23(4):415-420. doi: 10.4103/aja.aja_72_20. Asian J Androl. 2021. PMID: 33473011 Free PMC article.

8

Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels.

Tanaka N, Fujimoto K, Chihara Y, Torimoto M, Hirao Y, Konishi N, Saito I. Tanaka N, et al. Prostate Cancer Prostatic Dis. 2007;10(3):274-8. doi: 10.1038/sj.pcan.4500957. Epub 2007 Mar 6. Prostate Cancer Prostatic Dis. 2007. PMID: 17339878

9

Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD).

Falagario UG, Jambor I, Lantz A, Ettala O, Stabile A, Taimen P, Aronen HJ, Knaapila J, Perez IM, Gandaglia G, Fossati N, Martini A, Cucchiara V, Picker W, Haug E, Ratnani P, Haines K, Lewis S, Sujit N, Selvaggio O, Sanguedolce F, Macarini L, Cormio L, Nordström T, Tewari A, Briganti A, Boström PJ, Carrieri G. Falagario UG, et al. Eur Urol Oncol. 2021 Dec;4(6):971-979. doi: 10.1016/j.euo.2020.08.014. Epub 2020 Sep 21. Eur Urol Oncol. 2021. PMID: 32972896

10

Intermediate versus low or high prostate-specific antigen density level: comparison of cancer detection rate between 12- and 18-core prostate biopsy.

Park HK, Lee KY, Kim KH, Jung H, Yoon SJ, Kim TB. Park HK, et al. Scand J Urol Nephrol. 2010 Dec;44(6):391-8. doi: 10.3109/00365599.2010.508049. Epub 2010 Aug 9. Scand J Urol Nephrol. 2010. PMID: 20695726 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year